Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
International Neurorehabilitation Institute is a private U.S. neurology and neurorehabilitation practice based in Lutherville, Maryland. The organization provides outpatient neurological care, neurorehabilitation, physical and occupational therapy, and office-based infusion services for patients with multiple sclerosis, transverse myelitis, NMOSD, spinal cord injury, headaches, and other neurologic disorders. Founded and led by neurologist Daniel Becker, M.D., the practice emphasizes comprehensive care for adults and children with paralysis and related neurologic disability. In addition to rehabilitation services, INI administers a range of commercial infused neurologic and immunology therapies and participates in clinical research in areas including multiple sclerosis, transverse myelitis, and spinal cord injury. It appears to be a healthcare services organization rather than a drug-development biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Neurorehabilitation Institute.